OCTOPLUS SECURES $23.85 MILLION IN SECOND FINANCING ROUND

OctoPlus has raised $23.85 million in a second financing round from an international group of investors. The investment was led by Life Sciences Partners and S.R. One. The funds will be used primarily to further expand OctoPlus' portfolio of products based on its proprietary drug delivery platforms OctoDEX and PolyActive.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/www/story/01-20-2005/0002865884&EDATE=)